☰

Rebecca A. Juliano, Ph.D. - Publications

Affiliations: 
2004 Columbia University, New York, NY 
Area:
Nutrition, General Biophysics
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sherratt SCR, Juliano RA, Mason RP. Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro. Biochimica Et Biophysica Acta. Biomembranes. 183254. PMID 32135144 DOI: 10.1016/j.bbamem.2020.183254  0.361
2019 Miller M, Ballantyne CM, Bays HE, Granowitz C, Doyle RT, Juliano RA, Philip S. Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study). The American Journal of Cardiology. PMID 31277790 DOI: 10.1016/J.Amjcard.2019.05.057  0.315
2019 Ballantyne CM, Manku MS, Bays HE, Philip S, Granowitz C, Doyle RT, Juliano RA. Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiology and Therapy. PMID 30788718 DOI: 10.1007/s40119-019-0131-8  0.348
2016 Ballantyne CM, Bays HE, Philip S, Doyle RT, Braeckman RA, Stirtan WG, Soni PN, Juliano RA. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies. Atherosclerosis. 253: 81-87. PMID 27596132 DOI: 10.1016/j.atherosclerosis.2016.08.005  0.404
2016 Ballantyne CM, Bays HE, Braeckman RA, Philip S, Stirtan WG, Doyle RT, Soni PN, Juliano RA. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies. Journal of Clinical Lipidology. 10: 635-645.e1. PMID 27206952 DOI: 10.1016/j.jacl.2016.02.008  0.426
2015 Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Doyle RT, Philip S, Soni PN, Juliano RA. Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 13: 239-47. PMID 25893544 DOI: 10.1089/met.2014.0137  0.315
2004 Worgall TS, Juliano RA, Seo T, Deckelbaum RJ. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 943-8. PMID 15132973 DOI: 10.1161/01.Atv.0000125703.20434.4D  0.501
2004 Worgall TS, Davis-Hayman SR, Magana MM, Oelkers PM, Zapata F, Juliano RA, Osborne TF, Nash TE, Deckelbaum RJ. Sterol and fatty acid regulatory pathways in a Giardia lamblia-derived promoter: evidence for SREBP as an ancient transcription factor. Journal of Lipid Research. 45: 981-8. PMID 14967824 DOI: 10.1194/Jlr.M400024-Jlr200  0.536
2004 Juliano RA, Deckelbaum RJ, Worgall TS. Fatty acids, cholesterol, and sphingolipids: interactive regulators and targets for SREBP processing International Congress Series. 1262: 55-58. DOI: 10.1016/j.ics.2003.12.094  0.548
2003 Deckelbaum R, Juliano R, Worgall T. 1SY01-3 Fatty acids, cholesterol, and sphingolipids: Interactive regulators and targets for SREBP processing Atherosclerosis Supplements. 4: 3. DOI: 10.1016/S1567-5688(03)90015-8  0.548
Show low-probability matches.